Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers

Saved in:
Bibliographic Details
Published in:The Oncologist
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871837889304723457
collection WordPress RSS
FRELIP Feed Integration
container_title The Oncologist
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:106646
institution FRELIP
journal_source_facet The Oncologist
last_indexed 2026-07-27T03:41:59.391Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
title_alt Corrección a: Análisis de seguridad a largo plazo de datos agrupados para tislelizumab como monoterapia o en combinación con quimioterapia en pacientes con cánceres avanzados
Correction de : Analyse de sécurité à long terme des données regroupées pour le tislelizumab en monothérapie ou en association avec une chimiothérapie chez les patients atteints de cancers avancés
Correção para: Análise de Segurança de Longo Prazo de Dados Agrupados para Tislelizumabe como Monoterapia ou em Combinação com Quimioterapia em Pacientes com Cânceres Avançados
title_auth Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
title_es_txt Corrección a: Análisis de seguridad a largo plazo de datos agrupados para tislelizumab como monoterapia o en combinación con quimioterapia en pacientes con cánceres avanzados
title_fr_txt Correction de : Analyse de sécurité à long terme des données regroupées pour le tislelizumab en monothérapie ou en association avec une chimiothérapie chez les patients atteints de cancers avancés
title_full Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
title_fullStr Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
title_full_unstemmed Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
title_pt_txt Correção para: Análise de Segurança de Longo Prazo de Dados Agrupados para Tislelizumabe como Monoterapia ou em Combinação com Quimioterapia em Pacientes com Cânceres Avançados
title_short Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
title_sort correction to: long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
topic Oncology
General
Oncology
url https://academic.oup.com/oncolo/article/doi/10.1093/oncolo/oyag061/8741392?rss=1